TITLE

PhRMA announces new code of conduct

PUB. DATE
September 2008
SOURCE
Marketing Health Services;Fall2008, Vol. 28 Issue 3, p4
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports that the Pharmaceutical Research and Manufacturers of America (PhRMA) has created an updated code of ethics for pharmaceutical marketing in 2008. According to the new code of ethics, pharmaceutical companies would not be allowed to provide meals for doctors or other items that advertise a drug. Some people think PhRMA should adopt even stricter policies.
ACCESSION #
35794491

 

Related Articles

  • Drug industry ad code seen as negotiating ploy. Thomaselli, Rich // Advertising Age;8/8/2005, Vol. 76 Issue 32, p8 

    Presents views on the code of conduct issued for the Pharmaceutical Research and Manufacturers of America in August 2005. Number of pharmaceutical companies that signed off on the code; Information on the guidelines created for the marketing of prescription drugs.

  • Pharma Ethics Code Isn't Working! Verschoor, Curtis C. // Strategic Finance;Feb2011, Vol. 92 Issue 8, p17 

    The article argues that a code of ethics put forth by the Pharmaceutical Research and Manufacturers of America (PhRMA) to regulate marketing in the pharmaceutical industry has not been effective. The author describes various violations of the code detailed in a report from independent...

  • Ban advertising in Australian prescribing software, say researchers. Burton, Bob // BMJ: British Medical Journal (International Edition);7/23/2005, Vol. 331 Issue 7510, p177 

    Looks at the results of a survey on breaches of the Australian pharmaceutical industry's voluntary code of conduct; Recommendation of the survey that advertisements in prescription software be banned; Details of the survey's findings on the presence of advertisements in prescription software;...

  • Tight leash. Lentz, Rebecca // Modern Physician;Nov99, Vol. 3 Issue 11, p10 

    Talks about restrictions placed on drug representatives in the United States. Concerns over the liability of having myriad samples around the doctor's office; Drug samples that can be left in the sample closet; How drug representatives reacted to the restrictions.

  • Pharma Code Awareness Grows.  // Review of Ophthalmology;Apr2003, Vol. 10 Issue 4, p10 

    Reports that the pharmaceutical industry has done a fair job of educating its members on the details of the code of the Pharmaceutical Research and Manufacturers of America on marketing and promotion of drug products in the United States. Need for eye surgeons to better understand the code;...

  • A prescription for better prescriptions. Woosley, Raymond L. // Issues in Science & Technology;Spring94, Vol. 10 Issue 3, p59 

    Discusses the dependency of physicians on drug companies as the primary source of information about pharmaceuticals. High cost of marketing; Bias scientific literature; Prescribing practices of physicians; Establishment of federally funded centers for education and research in therapeutics...

  • Using market models to forecast demand for ethical pharmaceuticals. Latta, Michael // Journal of Business Forecasting Methods & Systems;Spring98, Vol. 17 Issue 1, p3 

    Discusses the use of market models to forecast demand for ethical pharmaceutical products. Scenarios to consider in forecasts; Creation of a base case using the patient market model; Need for management approval for assumptions used in the model.

  • Winning with Sports Celebrities. Hallahan, Mary // Pharmaceutical Executive;Jul2000, Vol. 20 Issue 7, p118 

    Discusses the popularity of the use of athletes by pharmaceutical companies to promote their health products. Reason behind the trend; Comments from Marc Reede, president of the Nationwide Speakers Bureau.

  • Feds Outline Risky Pharma Marketing Activities. Wechsler, Jill // Pharmaceutical Executive;Nov2002, Vol. 22 Issue 10, p32 

    Outlines risky drug marketing activities in the U.S. Providing of inaccurate price and sales data used to establish reimbursement rates and inflating wholesale prices; Inducements offered to physicians to purchase products; Consulting arrangements with healthcare professionals that disguise...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics